↓ Skip to main content

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients

Overview of attention for article published in Frontiers in Pharmacology, October 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
79 Mendeley
Title
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
Published in
Frontiers in Pharmacology, October 2020
DOI 10.3389/fphar.2020.582348
Pubmed ID
Authors

Vincenzo Russo, Andreina Carbone, Filiberto Fausto Mottola, Rosa Mocerino, Raffaele Verde, Emilio Attena, Nicoletta Verde, Pierpaolo Di Micco, Luigi Nunziata, Francesco Santelli, Gerardo Nigro, Sergio Severino

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 11%
Student > Bachelor 9 11%
Student > Doctoral Student 8 10%
Student > Ph. D. Student 7 9%
Other 6 8%
Other 17 22%
Unknown 23 29%
Readers by discipline Count As %
Medicine and Dentistry 27 34%
Pharmacology, Toxicology and Pharmaceutical Science 5 6%
Environmental Science 3 4%
Neuroscience 3 4%
Nursing and Health Professions 2 3%
Other 13 16%
Unknown 26 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2020.
All research outputs
#15,588,166
of 23,248,929 outputs
Outputs from Frontiers in Pharmacology
#6,531
of 16,686 outputs
Outputs of similar age
#255,221
of 415,365 outputs
Outputs of similar age from Frontiers in Pharmacology
#152
of 421 outputs
Altmetric has tracked 23,248,929 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,686 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 415,365 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 421 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.